The Drug Regulatory Authority of Pakistan (DRAP) has notified new guidelines for the registration of medicines in the country in line with World Health Organization (WHO) guidelines.
The new framework is aimed at making the drug registration process more transparent, efficient, and consistent with international standards.
Under the guidelines, applicants will be provided with complete information before registration, while pharmaceutical companies will receive full facilitation during the submission of their applications.
DRAP has also taken international standards related to the quality and efficacy of medicines into account while developing the guidelines.
The new framework is expected to harmonize the regulatory review process for drug registration in Pakistan and improve accountability and transparency.
A more efficient registration process is also expected to facilitate timely access to quality medicines in the country.
The post DRAP Introduces New Guidelines for Medicine Registration appeared first on ProPakistani.
